If introduced, the 100% tariffs would apply to all generic drugs imported to the US, which make up 90% of the nation’s prescriptions.

In a lawsuit filed in the US, Novo alleged that Lilly’s campaign was designed to mislead consumers on “comparative efficacy” of drug brands.

Despite a lacklustre start to the year, Novartis seems to have overcome its financial slump, reporting operating profits in Q2 that exceeded analyst expectations. The Swiss drugma ...

BMS enhances its AI computing power with NVIDIA's DGX SuperPOD as big pharma race to stay competitive within the shifting global landscape.

The EMA’s CHMP has granted PRIME designation to AbelZeta Pharma’s C-CAR168, an autologous anti-CD20/BCMA CAR-T therapy.

Halozyme Therapeutics has signed a global partnership and licence agreement with Incyte to assess additional subcutaneous formulations of INCA033989 in patients with mutCALR-expressing MPNs.

The JCA process does not have any influence over pricing and Ipsen must still navigate reimbursement access on a country-by-country basis. Credit: HJBC / Shutterstock.com. The first published joint ...

The therapies’ availability will offer a route to personalised, mutation-specific approaches for types of rare blood cancers.

Samsung Biologics is set to acquire PolyPeptide Group through an all-cash public tender offer valued at SFr1.46bn ($1.81bn).

UK biotech financing recovery was present in the private markets in Q2 2026 as the sector contends with a tough global funding landscape.

Aptar Pharma has launched a collaborative system-level framework designed to support the development of injectable drug delivery systems.

Bayer's Kerendia will become available to English patients with chronic heart failure with preserved or mildly reduced ejection fraction.